Press release
Challenges including Obtaining Funding and Lack of Incentives for Researchers Hinder Antimicrobial Resistance Research
Superbugs & Superdrugs 2019
The two-day conference is set to give an in-depth analysis on the various strategies in place to support antimicrobial resistance research & development, the latest scientific advancements for tackling antimicrobial resistance, as well as potential novel candidates and alternatives to anti-microbials.
This year's event will not only provide the latest updates on antimicrobial research development, but will also focus on strategies companies use to assist development of new therapies. In addition, attendees will also learn about obtaining funding, and why there's a lack of incentives for researchers working in antimicrobial resistance research and development.
John Rex, Chief Medical Officer at F2G will be presenting at this year’s conference on “Anti-Infective Research: Funding, Filing and Finance”, where he will provide updates on funding initiatives, recent changes in the regulatory landscape, and payer models: evolving global discussions.
The 21st annual conference will host an international gathering of expert speakers from industry-leading organisations with the aim of sharing their combined experience and expertise about the ever-evolving threat of antibiotic resistance.
FEATURED EXPERT SPEAKERS:
• Mair Powell, Senior Medical Officer, HPRA
• John Rex, Chief Medical Officer & Director, F2G
• David Cook, Chief Scientific Officer, Blueberry Therapeutics
• David Roblin, President of R&D, Chief Operating Officer and Chief Medical Officer, Summit Therapeutics
• Stephen A. Barat, Head of Pre-Clinical Research and Early Clinical Development, Scynexis
• Kazunori Maebashi, Senior Project Manager, Meiji Seika Pharma
• Chandrabali Ghose, CEO, Bioharmony Therapeutics
• Professor Eiríkur Steingrimsson, Co-founder, Akthelia Pharmaceuticals
• Chris Pickford, Head of Drug Discovery, Centauri Therapeutics
• Professor Christopher Schofield, Head of Organic Chemistry, Oxford University
• + many more!
Download the brochure on the event website to see the two-day agenda and speaker line-up at http://www.superbugssuperdrugs.com/openpr. Book your place before 30th November to save £400.
Superbugs & Superdrugs
18th & 19th March 2019
Holiday Inn Kensington Forum, London, UK
About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
SMi Group Ltd
1 Westminster Bridge Rd, South Bank, London SE1 7XW
Maria Mandic
mmandic@smi-online.co.uk
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Challenges including Obtaining Funding and Lack of Incentives for Researchers Hinder Antimicrobial Resistance Research here
News-ID: 1361792 • Views: …
More Releases from SMi Group
Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Con …
SMi Reports: Exclusive speaker interview with Todd Krueger at AOBiome released for the Pain Therapeutics Conference
The pain therapeutics industry has grown at an exponential rate in recent years. The 22nd Annual Pain Therapeutics conference will cover the leading advances in pain therapeutics, exploring late development clinical trials, novel treatments for chronic conditions, technology collaboration treatments, using VR and Medical Devices that carry out non-invasive nerve stimulation.
Industry leaders will uncover the…
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual High …
Now in its 6th year, the Highly Potent Active Pharmaceutical Ingredients conference offers you peer-to-peer networking with industry experts including heads and directors of EHS, Occupational Hygiene, Quality Assurance and more. Taking place on 9th and 10th May in London, UK.
With a key focus on expanding your community and exploring the latest developments in the industry at this two-day event, including key regulatory updates, and leading case studies from leading…
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast C …
SMi Group Reports: Keynote FDA speaker Dr. John Arigo, to present at the 4th Annual Pharmaceutical Microbiology East Coast, taking place in just 3 weeks' time on April 27th and 28th, 2022.
With just three weeks remaining until the highly anticipated conference, SMi Group are delighted to announce a key FDA Speaker joining the 5th Annual Pharmaceutical Microbiology East Coast Conference. This event will take place on April 27th and…
Group Captain (ret'd) Robert Daisley invites you to attend Air Mission Planning …
SMi Group reports: Chairman Group Captain (ret'd) Robert Daisley of the Air Mission Planning and Support Conference cordially invites experts to join the conference in London, UK in one week.
With only one week remaining, SMi Group is delighted to publish an invitation letter for SMi's 13th Annual Air Mission Planning & Support Conference, taking place on the 6th and 7th April 2022 in London, UK from the conference chairman.
The…
More Releases for Superbugs
Antibiotics Market - Battling Superbugs: Cutting-Edge Antibiotics for Resistant …
Newark, New Castle, USA: The "Antibiotics Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Antibiotics Market: https://www.growthplusreports.com/report/antibiotics-market/7752
This latest report researches the industry structure, sales, revenue, price and…
1 week to go to SMi's 22nd Annual Superbugs & Superdrugs Conference
SMi Reports: Superbugs & Superdrugs conference taking place next week, will now be by remote access only
With only 1 week remaining, the 22nd Annual Superbugs & Superdrugs Conference will reconvene on the 30 and 31 March, with remote access only. This year's global focused two-day conference pharmaceutical is for industry professionals looking to gain an in-depth knowledge of the scientific, economic, and regulatory challenges facing the critical global issue of…
Interview with Martin Everett speaker at SMi's Superbugs & Superdrugs Conference
SMi Reports: An Interview with Martin Everett, Chief Scientific Officer, at Antabio, who will be speaking at SMi's highly anticipated 22nd Annual Superbugs & Superdrugs Conference on the 30th and 31st March 2020 in London.
This year's global focused two-day conference pharmaceutical is for industry professionals looking to gain an in-depth knowledge of the scientific, economic, and regulatory challenges facing the critical global issue of antibiotic resistance.
For interested individuals to attend…
Evotec & Scynexis to lead the workshops for Superbugs & Superdrugs 2020
SMi Reports: Interactive workshop overview for SMi's 22nd Annual Superbugs & Superdrugs Conference, London in March 2020
SMi’s highly anticipated 22nd Annual Superbugs & Superdrugs Conference will commence on the 30th and 31st March 2020 and in London, UK.
For this year’s conference, industry leaders and key profiles from leading pharmaceutical organisations will be brought together to discuss the strategies in place that reduce AMR, evaluate the role pharmaceutical companies and funding…
SMi’s 22nd Annual Superbugs & Superdrugs Conference 2020 – Speakers Announce …
SMi Reports: the agenda and speaker overview of the upcoming SMi’s 22nd Annual Superbugs & Superdrugs Conference 2020, in London is now available to view.
SMi Group is delighted to announce the return of the successful Superbugs & Superdrugs Conference for its 22nd year, taking place on 30th and 31st March 2020 at the Holiday Inn Kensington Forum in London. Antibiotics have long been one of the most important pharmaceuticals…
Four weeks until SMi’s 21st Annual Superbugs & Superdrugs Conference 2019
SMi Reports: Senior industry experts will gather in London to discuss the recent advances made in combating antibiotic resistance.
As the global threat of antimicrobial resistance continues to grow, the advances of modern medicines are at risk of being lost. Failure to act quickly means the spread of antibiotic-resistant bacteria could lead to increased mortality from normally minor injuries and benign infections.
For this reason, the Superbugs & Superdrugs conference, taking…
